Andy Taylor execute real-time at The Roxy at the Duran Duran reveal provided by DKNY Jeans as well as The Fader. KMazur/WireImage
Duran Duran guitar player Andy Taylor is sharing some favorable information regarding his fight with cancer.
The 62-year-old artist, that revealed his phase 4 prostate cancer cells medical diagnosis in November 2022 (he was at first identified in 2018), states he anticipates to live one more 5 years many thanks to a “nuclear medicine” called Lutetium-177.
Taylor informs BBC Breakfast that researchers called him regarding the medication, which is made to made to particularly target cancer cells.
“It can’t see healthy cells,” states Taylor, that had his very first therapy regarding 6 weeks back. “It kills stage four cancer in your bones. And so what it’s effectively done is extend my life for five years.”
Lutetium-177 was accepted by the U.S. Food as well as Drug Administration in March 2022. The medication has “proven to significantly improve prostate cancer survival rates and quality of life, as well as extend the time it takes for the disease to progress,” according to the University of Chicago Medical Center.
Taylor disclosed his cancer cells medical diagnosis via a letter reviewed by his bandmates throughout their induction right into the Rock & Roll Hall last November. The guitar player was anticipated to sign up with participants Simon LeBon, John Taylor, Nick Rhodes as well as Roger Taylor at the team’s induction in Los Angeles, however needed to miss it because of his health problem.
Taylor informed BBC that he was “massively disappointed” to miss out on the Rock Hall event, which he described as “the biggest night of my life.”
The guitar player states the Lutetium-177 therapy is permitting him to complete his future solo cd, Man’s a Wolf to Man, which is arranged for launch in September.
Earlier this year, Duran Duran confirmed that Taylor will certainly be adding to the team’s honest cd. The band is additionally recognizing the guitar player with a one-off benefit concert for cancer cells understanding at the Guild Theatre in Menlo Park, Calif., on Aug. 19.
